-
Something wrong with this record ?
Re: DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial
E. Laukhtina, SF. Shariat
Language English Country Switzerland
Document type Randomized Controlled Trial, Journal Article, Comment
- MeSH
- Administration, Intravesical MeSH
- Neoplasm Invasiveness MeSH
- Humans MeSH
- Neoplasm Recurrence, Local drug therapy MeSH
- Mitomycin * therapeutic use MeSH
- Urinary Bladder Neoplasms * drug therapy surgery MeSH
- Antibiotics, Antineoplastic therapeutic use MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Comment MeSH
- Randomized Controlled Trial MeSH
Department of Urology 2nd Faculty of Medicine Charles University Prague Czechia
Department of Urology Comprehensive Cancer Center Medical University of Vienna Vienna Austria
Department of Urology University of Texas Southwestern Dallas TX USA
Department of Urology Weill Cornell Medical College New York NY USA
Hourani Center for Applied Scientific Research Al Ahliyya Amman University Amman Jordan
Institute for Urology and Reproductive Health Sechenov University Moscow Russia
Karl Landsteiner Institute of Urology and Andrology Vienna Austria
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24000924
- 003
- CZ-PrNML
- 005
- 20240213093506.0
- 007
- ta
- 008
- 240109s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.eururo.2023.05.028 $2 doi
- 035 __
- $a (PubMed)37270391
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Laukhtina, Ekaterina $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia
- 245 10
- $a Re: DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial / $c E. Laukhtina, SF. Shariat
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a mitomycin $x terapeutické užití $7 D016685
- 650 12
- $a nádory močového měchýře $x farmakoterapie $x chirurgie $7 D001749
- 650 _2
- $a protinádorová antibiotika $x terapeutické užití $7 D000903
- 650 _2
- $a aplikace intravezikální $7 D000283
- 650 _2
- $a invazivní růst nádoru $7 D009361
- 650 _2
- $a lokální recidiva nádoru $x farmakoterapie $7 D009364
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a komentáře $7 D016420
- 700 1_
- $a Shariat, Shahrokh F $u Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czechia; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Electronic address: shahrokh.shariat@meduniwien.ac.at
- 773 0_
- $w MED00001669 $t European urology $x 1873-7560 $g Roč. 84, č. 5 (2023), s. 512-513
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37270391 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213093503 $b ABA008
- 999 __
- $a ok $b bmc $g 2049507 $s 1210618
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 84 $c 5 $d 512-513 $e 20230601 $i 1873-7560 $m European urology $n Eur Urol $x MED00001669
- LZP __
- $a Pubmed-20240109
